SLAMF7 and plasma cell myeloma: Recently, Kikuchi et al. have reported that the soluble form of SLAMF7 could increase myeloma cell proliferation in vitro and in vivo and that knockdown of surface SLAMF7 cancelled the proliferative function of soluble SLAMF7 in vitro [36].